MoneyWorks4Me

Dr Reddy’s Laboratories enters into Colombian market to sell cancer drugs

08 Oct 2016 Evaluate

Dr Reddy’s Laboratories has forayed into the Colombian market with its portfolio of high quality and affordable medicines for cancer drugs.

The Hyderabad-based firm operates in all major markets including the US, Russia, CIS countries and Europe with a workforce of above 20,000 employees. Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.

 

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..